US Patent Issued to CYTOKINETICS on June 9 for "Polymorphs of (R)-N-(5-(5-isopropyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-methyl-2H-tetrazole-5-carboxamide" (California Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,732, issued on June 9, was assigned to CYTOKINETICS INC. (South San Francisco, Calif.).

"Polymorphs of (R)-N-(5-(5-isopropyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-methyl-2H-tetrazole-5-carboxamide" was invented by Norma Tom (Belmont, Calif.) and Denise Andersen (Montara, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are polymorphs of (R)-N-(5-(5-isopropyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-methyl-2H-tetrazole-5-carboxamide, compositions thereof, methods of preparation thereof, and methods of their uses."

The patent was filed on July 16, 2020, under Application No. 17/627,590.

*For further informa...